Showing results (1891-1900 of 2,171) with videos related to

Sort By:
Pageof 218
The British Journal of Dermatology|March 28, 2019
Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trialsG B E Jemec, M M Okun, S B Forman, et al.
Circulation|November 3, 1998
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa InvestigatorsL K Newby, R H Christenson, E M Ohman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 15, 2024
Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 PopulationJonathan Corren, Stanley J Szefler, Ellen Sher, et al.
Journal of Cardiac Failure|April 22, 2004
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristicsBarry M Massie, William F Krol, Susan E Ammon, et al.
European Heart Journal|March 13, 2008
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIbRajendra H Mehta, Sunil V Rao, E Magnus Ohman, et al.
Circulation|March 18, 2009
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trialBarry M Massie, Joseph F Collins, Susan E Ammon, et al.
American Heart Journal|October 8, 2013
Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trialPadma Kaul, Jean-François Tanguay, L Kristin Newby, et al.
Journal of the American College of Cardiology|July 14, 2001
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization NetworkP Kaul, Y Fu, W C Chang, et al.
CJC Open|February 24, 2022
Prevalence of Cardiovascular Disease in a Population-Based Cohort of High-Cost Healthcare Services UsersPadma Kaul, Nathan Klassen, Douglas C Dover, et al.
JACC. Cardiovascular Interventions|July 21, 2012
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomesAdriano A M Truffa, Christopher B Granger, Kyle R White, et al.
Pageof 218